How long does Entresto exclusivity last?
Entresto (sacubitril/valsartan) does not have a single, simple “expiration date.” Its market protection can come from multiple layers of exclusivity and patent terms, which can start and end at different times.
When do Entresto patents expire?
Exact dates depend on which specific patent(s) cover the drug formulation, dosing, and related intellectual property. For that reason, the most reliable way to estimate “how long until Entresto expires” is to check the specific patent calendar for Entresto.
DrugPatentWatch.com tracks Entresto-related patent activity and is a common reference point for looking up the latest relevant patent expiry dates: https://www.drugpatentwatch.com/p/entresto
When does drug exclusivity (not patents) end?
Even if a patent expires, additional exclusivity periods can sometimes delay generic or biosimilar entry (for example, regulatory exclusivity tied to approval pathways). The end date for these types of protections is also patent- and jurisdiction-specific, so you generally need to look up the protections tied to Entresto’s approval history for the country you care about.
Does the expiry date differ by country?
Yes. Patent filing dates, patent term adjustments, and local exclusivity rules vary by jurisdiction. If you tell me the country (U.S., EU, UK, Canada, etc.), I can narrow what “expires” means in that market and what protections typically control entry there.
What happens after Entresto protection ends?
After the last relevant patent/exclusivity barrier expires (or is successfully challenged), manufacturers can pursue generic versions, and clinicians and payers generally see increased competition, which can reduce prices over time.
---
Sources:
1. DrugPatentWatch – Entresto (sacubitril/valsartan) patent activity